Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    PITUITARY ADENOMA, ACTH-SECRETING
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Conditions: Cushing's Disease;   Corticotroph Adenoma
Intervention: Drug: Cabergoline
2 Terminated
Has Results
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Intervention: Drug: rosiglitazone maleate
3 Recruiting Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Intervention: Drug: R-roscovitine
4 Active, not recruiting Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide with or without cabergoline
5 Active, not recruiting Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Intervention: Drug: LCI699
6 Active, not recruiting An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Condition: Cushing's Disease
Intervention: Drug: Pasireotide sub-cutaneous formulation
7 Recruiting Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: osilodrostat;   Drug: osilodrostat Placebo
8 Not yet recruiting Assessment of Persistent Cognitive Impairment After Cure of Cushing's Disease
Condition: Cushing's Disease
Intervention: Device: Virtual radial task in 3D
9 Recruiting Cushing's Disease Complications
Condition: Cushing's Disease
Intervention: Other: Exams and questionnaires
10 Active, not recruiting Cushing´s Disease Epidemiology in Sweden
Condition: Cushing Disease
Intervention:
11 Recruiting Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
Condition: Cushings Disease
Intervention: Drug: SOM230
12 Recruiting Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: LCI699
13 Withdrawn Mifepristone in Children With Refractory Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: mifepristone
14 Active, not recruiting Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition: Cushing's Disease
Interventions: Drug: SOM230 LAR 30 mg;   Drug: SOM230 LAR 10 mg
15 Withdrawn Long-term Cardiovascular Risk in Cured Cushing's Patients
Condition: Cushing's Disease
Intervention:
16 Unknown  Preoperative Bexarotene Treatment for Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Bexarotene
17 Completed
Has Results
Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: Pasireotide
18 Completed Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition: Cushing Disease
Intervention: Drug: Pasireotide
19 Recruiting Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools
Conditions: Pituitary Neoplasms;   Prolactinoma;   ACTH-Secreting Pituitary Adenoma;   Gigantism;   Growth Hormone-Secreting Pituitary Adenoma
Intervention: Other: Educational Intervention
20 Completed A Study to Assess SOM230 in Patients With Pituitary Cushing's Disease
Condition: Cushing's Syndrome
Intervention: Drug: SOM230 s.c.

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.